Vaccine Makers' Stocks Fall Amid Regulatory Tightening

Major vaccine manufacturers face potential regulatory challenges following an internal FDA memo suggesting a link between COVID-19 vaccines and child deaths. The memo, sent by Vinay Prasad, proposes new oversight and review processes, causing stock prices for Moderna, Novavax, BioNTech, and Pfizer to fall. Analysts anticipate these restrictions will create additional hurdles for companies in completing trials and bringing new treatments to market.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.